Results 241 to 250 of about 334,749 (357)

FcRn-guided antigen trafficking enhances cancer vaccine efficacy. [PDF]

Cancer Immunol Immunother
Hong M, Liu M, Zhu F, Zhao D, Liu G, Han T, Fei C, Zeng W, Chen S, Wu Q, Li B, Wu S, Shang Y, Ma H, Zhou S, Xu S, Jin T.   +16 more
europepmc   +1 more source

Cancer vaccine strategies for the treatment of diffusely infiltrating gliomas. [PDF]

Ther Adv Vaccines Immunother, 2023
Jucht A, Dumont S, Pooley C, Gonzalez Castro LN.   +3 more
europepmc   +1 more source

Treating Colon Cancer With a Melanoma Vaccine? Preposterous? [PDF]

, 2001
Vernon K. Sondak
openalex   +1 more source

The Induction and Characterization of a Potential Rough‐Type Brucella Vaccine Candidate Strain RA343, and Its Safety, Protective Efficacy in Mouse and Guinea Pig Models

Animal Research and One Health, EarlyView.
Brucellosis is a zoonotic disease caused by Brucella spp. which seriously jeopardize the health and safety of animals and human beings. In this study, a genetically stable Brucella rough RA343 strain was obtained by cross‐induction. The virulence and protective efficacy of RA343 were subsequently assessed. Overall, the RA343 strain is a promising novel
Linjiao Li, Guangzhi Zhang, Minghe Liu, Lang Lv, Xiaowei Peng, Yu Feng, Xiaotong Yang, Jiabo Ding, Chunhai Liu, Jianhua Qin, Peng Li, Hui Jiang, Xuezheng Fan   +12 more
wiley   +1 more source

Challenges and New Directions in Therapeutic Cancer Vaccine Development. [PDF]

Vaccines (Basel)
Pan D, Liu J, Huang X, Wang S, Kuerban K, Yan Y, Zhu YZ, Ye L.   +7 more
europepmc   +1 more source

Viral metagenomic analysis reveals potential biological hazards in non‐human primates in a zoo

Animal Research and One Health, EarlyView.
The investigation identifies the presence of Encephalomyocarditis virus (EMCV), Baboon endogenous virus (BAV), Human endogenous retrovirus (HERV), and Baboon endogenous virus (BaEV) in non‐human primates (NHPs) at the Zoo, indicating potential zoonotic threats.
Ruiying Liang, Xinming Tang, Lin Liang, Jiabo Ding, Ye Tian, Yixian Qin, Sufen Zhao, Lixia Zhang, Tianchun Pu, Xuefeng Liu, Jinpeng Liu, Chenglin Zhang, Zibin Li, Ting Jia   +13 more
wiley   +1 more source

Antigen targeting to dendritic cells: Still a place in future immunotherapy?

European Journal of Immunology, Volume 52, Issue 12, Page 1909-1924, December 2022., 2022
Dendritic cell‐based immunotherapy is a promising vaccination strategy to treat infectious diseases, autoimmunity, and cancer. In this review, we present an overview on the current state of antigen targeting approaches via C‐type lectin receptors, with an outlook on future developments and potential for clinical translation.
Patrizia Stoitzner, Nikolaus Romani, Christoph Rademacher, Hans Christian Probst, Karsten Mahnke   +4 more
wiley   +1 more source

Combination therapy with alisertib enhances the anti-tumor immunity induced by a liver cancer vaccine. [PDF]

iScience
Xue F, Liu J, Wu J, Li X, Zhu N, Tang S, Zhang M, Duan H, Wang R, Zhang J.   +9 more
europepmc   +1 more source

Expert Perspectives on a Clinical Challenge: Hematologic Malignancies and Vasculitis

Arthritis &Rheumatology, Accepted Article.
Systemic vasculitis describes a collection of rare diseases each caused by inflammation of blood vessel walls that can cause severe systemic complications [[3, 4]](#ref‐0003). The pattern of vascular inflammation and resultant damage is frequently variable and may be mimicked, or directly triggered, by infection or malignancy.
Michelle L. Robinette, Hetty E. Carraway
wiley   +1 more source

Off-The-Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma. [PDF]

Adv Mater
Moura LI, Malfanti A, Matos AI, Peres C, Armiñán A, Duro-Castaño A, Conejos-Sánchez I, Medel M, Đorđević S, Carrascosa P, Carreira B, Acúrcio RC, Xavier-Ferreira H, Hernández-Barranco A, Castellano E, Roselló E, Machado JC, Peinado H, Vicent MJ, Florindo HF.   +19 more
europepmc   +1 more source